Jinendiran Sekar
- Lundquist Institute for Biomedical Innovation at Harbor-Ucla Medical Center · Internal Medicine (investigator's affiliation)
From the FY2026 NIH awards this investigator leads as contact PI. The department is the award's.
FY2026 NIH rank #33,878
- Early Career
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 16460900Search this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2026 onlyCareer claims are limited to the years shown.
NIH Funding · FY2026
Linked Award Amount
$474.6K
Full award amounts, FY2026
Award Records
1
Records listing this PI
Award-Linked Rank
#33,878
By linked amount among FY2026 PIs
Earliest Year Loaded
2026
ScienceDex PI coverage
Award data coverage
ScienceDex currently has one fiscal year of PI ranking data for this record. This does not establish the first NIH award or current employer.
Single fiscal year on record (FY2026): $474.6K in linked award amounts across 1 award record · Award-linked rank #33878.
FY2026 award records by amount
NIH award records listing Jinendiran Sekar as a PI. Multi-PI records show the full award amount for context.
- 1R21DE036346-01R21Contact PIImmunometabolic and epigenetic dysregulation of oral mucosal immunity in diabetes-associated candidiasisLundquist Institute for Biomedical Innovation at Harbor-Ucla Medical Center · Internal Medicine (investigator's affiliation)$474.6Kaward amount
Award organization
Organizations that administered FY2026 awards listing Jinendiran Sekar as a PI.
FY2026 award administered by Lundquist Institute for Biomedical Innovation at Harbor-Ucla Medical Center (CA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2026First NIH AwardLundquist Institute for Biomedical Innovation at Harbor-Ucla Medical Center